Experimental Drug Hailed as Breakthrough for Pancreatic Cancer, Doubling Survival Time
A new experimental drug that nearly doubles the survival time for patients with pancreatic cancer, extending it from six and a half months to 13 months, has been hailed as a significant breakthrough. The announcement of this successful late-stage treatment brought an audience of doctors and global oncology professionals to their feet.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)Sources
'Game changer' experimental drug doubles survival time for pancreatic cancer, trial shows
An experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world's deadliest cancers.
Read full article →Why doctors stood up and cheered mid-presentation for a historic pancreatic cancer treatment
The announcement of a successful late-stage treatment that nearly doubles the survival for patients with deadly pancreatic cancer brought an audience of doctors and other global oncology professions to their feet on Sunday.
By Barbara Kollmeyer
Read full article →
